Marek Babjuk holds a position of Professor of Urology at the Charles University, Prague, Czech Republic. He is also a Chairmen of the Department of Urology at the University Hospital of Motol and the 2nd Faculty of Medicine at the Charles University where he also holds the Vice-dean position since 2014. His main clinical interests are in field of Onco-urology, especially robotic and laparoscopic surgery of bladder cancer. In addition, he is interested in modern non-invasive and endoscopic methods and technologies for bladder cancer diagnosis. Professor Babjuk has been member and chairman of the EAU Working Panel on Non-muscle-invasive Bladder Cancer in the past. He is a past member of the international educational committee of the European School of Urology (ESU) and a past President of Czech Urological Society where he is still a Board member. He is also a member of the scientific board of the 2nd Faculty of Medicine at Charles University, Czech Medical Council and Czech Health Ministry. In addition to teaching Urology at Charles University, he is an adjunct professor at the Medical University Vienna and visiting professor at Chinese University of Hong Kong. Professor Babjuk authored and co-authored more than 220 original peer-reviewed articles listed in PubMed. He is a member of the editorial board of several scientific journals, including World Journal of Urology, Czech Urology (the official journal of the Czech Urological Society) and European Urology.
Selected publications from PubMed
Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program.
Koudelková M, Hejcmanová K, Babjuk M, Zachoval R, Ferda J, Bratt O, Chloupková R, Ngo O, Hejduk K, Válek V, Dušek L, Májek O
Eur Urol Open Sci. 2026 Sep;91:41-48 doi: 10.1016/j.euros.2026.07.003.
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study.
Gontero P, Soria F, Babjuk M, Burger M, Palou Redorta J, D'Andrea D, Pradere B, Moschini M, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, Mariappan P, van Rhijn BWG, Seisen T, Shariat SF, Teoh J, Xylinas E, Capoun O, Rai BP, Soukup V, Faba OR, Cohen D, Foster L, Beaud N, Girtner F, Breyer J, Hornak J, Einerhand SMH, Anract J, Bobjer J, Linares E, Rodriguez-Serranos A, Cathomas R, Saba K, Hernandez V, Lorente C, Rouanne M, Lebret T, Masson-Lecomte A, Rouprêt M, Sylvester RJ
Eur Urol Oncol. 2026 Aug;9(4):868-882 doi: 10.1016/j.euo.2026.05.005.
Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue.
Haq F, Chinchankar S, Ambite I, Ahmadi S, Tran H, Nazari A, Brisuda A, Hacek J, Babjuk M, Svanborg C
Cancer Metab. 2026 Jun 23;14(1) doi: 10.1186/s40170-026-00445-2.
Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus.
Gontero P, Perry R, Bridge D, Delattre DD, Vosgerau S, Wyn R, Stone M, Babjuk M
Eur Urol Oncol. 2026 Jun;9(3):652-659 doi: 10.1016/j.euo.2026.05.007.
Re: Durvalumab in Combination with BCG for BCG-naive, High risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 Trial.
Babjuk M
Eur Urol. 2026 Jun;89(6):552-553 doi: 10.1016/j.eururo.2026.01.021.
PLASMA+ The + in bipolar surgery for BPH and NMIBC treatment Welcome and Introduction to Plasma technology. - Dr. Joerg Rassler (Germany). En-bloc resection of NMIBC with Plasma. - Dr. Marek Babjuk (Czech Republic). Plasma Enucleation and Resection. - Dr. Eric Mandron (France). Day Case Pathway for TUR-BT and TUR-P. - Dr. Jeremy Nettleton (UK). Discussion and closing remarks - All faculty moderated by Dr. Joerg Rassler (Germany).
With Olympus
Published
Jan 2022
Plasma is one of the forward-looking energies used in transurethral operation techniques. In the upcoming event, the faculty, who are leading in the use of plasma in endourology, will give you background information about the physics of plasma, clinical experiences as well as tips and tricks for the handling of plasma. Plasma+ is the newest innovation in clinical application of this energy.
With Olympus
Published
Dec 2021
Help your network discover Dr. Marek Babjuk's clinical expertise.
